Moreover, we present in vivo evidence demonstrating that KFXOL suppresses the TGF-β1/Smad signaling pathway, suggesting a possible mechanism by which KFXOL alleviates pulmonary fibrosis. The gene discussed is TGFB1; the disease is pulmonary fibrosis.